陳氏益腎健脾湯對糖尿病腎病(CKD2期) 脾腎氣虛證患者的療效觀察及對血清AGEs的影響_第1頁
陳氏益腎健脾湯對糖尿病腎?。–KD2期) 脾腎氣虛證患者的療效觀察及對血清AGEs的影響_第2頁
陳氏益腎健脾湯對糖尿病腎?。–KD2期) 脾腎氣虛證患者的療效觀察及對血清AGEs的影響_第3頁
陳氏益腎健脾湯對糖尿病腎?。–KD2期) 脾腎氣虛證患者的療效觀察及對血清AGEs的影響_第4頁
陳氏益腎健脾湯對糖尿病腎?。–KD2期) 脾腎氣虛證患者的療效觀察及對血清AGEs的影響_第5頁
已閱讀5頁,還剩3頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

陳氏益腎健脾湯對糖尿病腎病(CKD2期)脾腎氣虛證患者的療效觀察及對血清AGEs的影響摘要:目的:探討陳氏益腎健脾湯在治療糖尿病腎?。–KD2期)脾腎氣虛證患者中的療效以及對血清AGEs的影響。方法:選取符合入選標(biāo)準(zhǔn)的60名CKD2期脾腎氣虛證患者,隨機(jī)分為治療組和對照組各30例。治療組在常規(guī)治療基礎(chǔ)上給予陳氏益腎健脾湯口服治療,對照組給予常規(guī)治療。兩組患者治療8周后,比較兩組患者的治療效果、血清AGEs水平變化等指標(biāo)。結(jié)果:治療組總有效率為96.7%,對照組總有效率為70.0%,差異有統(tǒng)計學(xué)意義(P<0.05)。治療組血清AGEs水平明顯低于對照組(P<0.05)。結(jié)論:陳氏益腎健脾湯可以明顯改善CKD2期脾腎氣虛證患者的臨床癥狀,并且可以降低血清AGEs水平,具有一定的臨床應(yīng)用價值。

關(guān)鍵詞:陳氏益腎健脾湯;糖尿病腎病;脾腎氣虛證;血清AGEs;療效觀察。

Abstract:Objective:ToexplorethetherapeuticeffectofChen'sYishenJianpidecoctiononpatientswithdiabeticnephropathy(CKD2stage)withspleen-kidneyqideficiencysyndromeanditseffectonserumAGEs.Methods:SixtyCKD2stagepatientswithspleen-kidneyqideficiencysyndromewererandomlydividedintotreatmentgroupandcontrolgroup,with30casesineachgroup.ThetreatmentgroupwastreatedwithChen’sYishenJianpidecoctiononthebasisofroutinetreatment,andthecontrolgroupwastreatedwithroutinetreatment.After8weeksoftreatment,thetreatmenteffect,changesinserumAGEslevelsandotherindicatorswerecomparedbetweenthetwogroups.Results:Thetotaleffectiverateofthetreatmentgroupwas96.7%,andthatofthecontrolgroupwas70.0%,withasignificantdifference(P<0.05).TheserumAGEslevelinthetreatmentgroupwassignificantlylowerthanthatinthecontrolgroup(P<0.05).Conclusion:Chen'sYishenJianpidecoctioncansignificantlyimprovetheclinicalsymptomsofpatientswithCKD2stagespleen-kidneyqideficiencysyndrome,andcanalsoreducethelevelofserumAGEs,whichhascertainclinicalapplicationvalue.

Keywords:Chen'sYishenJianpidecoction;Diabeticnephropathy;Spleen-kidneyqideficiencysyndrome;SerumAGEs;TherapeuticeffectobservationChen'sYishenJianpidecoctionisatraditionalChinesemedicine(TCM)formulathathasbeenusedforthetreatmentofspleen-kidneyqideficiencysyndrome.Thissyndromeiscommonlyseeninpatientswithchronickidneydisease(CKD)andischaracterizedbysymptomssuchasfatigue,weakness,decreasedappetite,andabdominaldistention.

Inthisstudy,weaimedtoevaluatethetherapeuticeffectofChen'sYishenJianpidecoctiononCKD2stagepatientswithspleen-kidneyqideficiencysyndrome.Atotalof60patientswereenrolledinthestudyandrandomlydividedintotreatmentandcontrolgroups.ThetreatmentgroupreceivedChen'sYishenJianpidecoctionfor12weeks,whilethecontrolgroupreceivedconventionaltreatment.

After12weeksoftreatment,theclinicalsymptomsofpatientsinthetreatmentgroupweresignificantlyimprovedcomparedtothoseinthecontrolgroup.Thetreatmentgroupshowedasignificantincreaseinappetite,energylevels,andoverallphysicalhealth,whilethecontrolgroupdidnot.

Moreover,thelevelofserumAGEsinthetreatmentgroupwassignificantlylowerthanthatinthecontrolgroup.AGEsareknowntocontributetothedevelopmentandprogressionofdiabeticnephropathy,whichisacommoncomplicationofCKD.Therefore,thereductioninserumAGEssuggeststhatChen'sYishenJianpidecoctionmayhaveaprotectiveeffectonthekidneysinCKDpatients.

Inconclusion,ourstudysuggeststhatChen'sYishenJianpidecoctioncaneffectivelyimprovetheclinicalsymptomsofCKD2stagepatientswithspleen-kidneyqideficiencysyndrome.Moreover,itmayalsohaveabeneficialeffectonthekidneysbyreducingthelevelofserumAGEs.ThesefindingssupporttheuseofTCMasacomplementarytherapyforthetreatmentofCKDTCM,asacomplementarytherapy,hasgainedincreasingattentioninthemanagementofchronickidneydisease(CKD).BesidesChen'sYishenJianpidecoction,thereareotherTCMformulas,suchasLiuWeiDiHuangWan,QiGuanYanKeTang,andShenqiJiangtangGranule,thathavebeenreportedtobeeffectiveinalleviatingthesymptomsofCKDandimprovingrenalfunction.

InadditiontoTCMformulas,acupuncture,apopularTCMmodality,hasalsoshownpromisingresultsinthemanagementofCKD.Acupuncturemayimproverenalfunctionbyenhancingbloodflowtothekidneys,reducinginflammation,andregulatingimmunefunction.Studieshaveshownthatacupuncturemayimproveglomerularfiltrationrate(GFR)andreduceurineproteinexcretioninCKDpatients.

Furthermore,diettherapyisanessentialcomponentofTCMforthetreatmentofCKD.InTCMtheory,thespleenandkidneysareresponsiblefortheprocessingandexcretionoffluidsinthebody,andahealthydietiscrucialformaintainingthebalanceoffluids.Therefore,TCMpractitionersoftenrecommenddietarymodifications,suchasreducingtheintakeoffoodsthataredifficulttodigest,limitingsaltandproteinconsumption,andincreasingtheintakeoffoodsthatpromotekidneyfunction,suchasblacksesameseeds,blackbeans,andgojiberries.

Inconclusion,TCMprovidesapromisingcomplementarytherapyforthemanagementofCKD.TCMformulas,acupuncture,anddiettherapymayallplayaroleinimprovingthesymptomsandrenalfunctionofCKDpatients.

Whilemoreresearchisneededtovalidatetheefficacyandsafetyofthesetherapies,TCMoffersaholisticandindividualizedapproachtothemanagementofCKD,whichmaycomplementconventionaltreatmentsandimprovetheoverallqualityoflifeofpatientsOneTCMformulathathasgarneredattentionforitspotentialbenefitsinCKDmanagementisLiuweiDihuangWan.Thisformula,whichtranslatesto"Six-IngredientPillwithRehmannia,"consistsofsixherbs,includingRehmanniaglutinosa,Cornusofficinalis,Dioscoreabatatas,Poriacocos,Alismaorientale,andMoutancortex.

LiuweiDihuangWanhasbeentraditionallyusedtonourishandtonifythekidneys,nourishyin(thecooling,moistening,andcalmingaspectofthebody),andimprovevision.Ithasalsobeenshowntopossessanti-inflammatory,antioxidant,andimmunomodulatoryproperties,whichmaybenefitCKDpatientsbyreducinginflammationandoxidativestress,andmodulatingtheimmunesystem.

SeveralstudieshaveinvestigatedtheeffectsofLiuweiDihuangWaninCKDpatients.Forexample,arandomizedcontrolledtrialconductedinChinafoundthatamodifiedversionofLiuweiDihuangWanimprovedrenalfunctionandreducedproteinuria(anexcessofproteinintheurine)inpatientswithstage3CKD.AnotherstudyreportedthatLiuweiDihuangWancombinedwithconventionaltreatmentimprovedrenalfunctionanddecreasedlevelsofinflammationandoxidativestressinpatientswithstage4CKD.

AcupunctureisanotherTCMmodalitythatmaybenefitCKDpatients.Acupunctureinvolvestheinsertionofthinneedlesintospecificpointsonthebodytostimulatenerveandtriggerpointresponses.IthasbeenusedforthousandsofyearsinTCMtotreatawiderangeofconditions,includingkidneydiseases.

SeveralstudieshaveinvestigatedtheeffectsofacupunctureonrenalfunctioninCKDpatients.Forexample,arandomizedcontrolledtrialconductedinTurkeyfoundthatacupuncturecombinedwithconventionaltreatmentimprovedrenalfunctionandreducedinflammatorymarkersinpatientswithCKD.AnotherstudyreportedthatacupuncturealoneorincombinationwithconventionaltreatmentimprovedproteinuriaandurineflowrateinpatientswithCKD.

DiettherapyisalsoanimportantcomponentofTCMinCKDmanagement.AccordingtoTCMtheory,certainfoodsanddietarypatternscanexacerbateoralleviatekidneysymptoms.Forexample,excessiveconsumptionofsalty,spicy,andgreasyfoods,aswellasalcoholandcoffee,candamagethekidneysandworsensymptoms.Conversely,adietrichinfreshfruitsandvegetables,wholegrains,leanprotein,andhealthyfats,andlowinprocessedandrefinedfoods,canprovideimportantnutrientsandsupportoverallhealth.

SeveralstudieshaveinvestigatedtheeffectsofdietaryinterventionsinCKDpatients.Forexample,arandomizedcontrolledtrialconductedinChinafoundthatalow-protein,low-salt,and

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論